These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 6727989

  • 1. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.
    Gunne LM, Häggström JE, Sjöquist B.
    Nature; ; 309(5966):347-9. PubMed ID: 6727989
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Experimental tardive dyskinesia.
    Gunne LM, Häggström JE.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pathophysiology of tardive dyskinesia.
    Gunne LM, Häggström JE.
    Psychopharmacology Suppl; 1985 Apr; 2():191-3. PubMed ID: 3858799
    [Abstract] [Full Text] [Related]

  • 6. An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia.
    Gunne LM, Andrén PE.
    Clin Neuropharmacol; 1993 Feb; 16(1):90-5. PubMed ID: 8093682
    [Abstract] [Full Text] [Related]

  • 7. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF.
    Psychopharmacology Suppl; 1985 Feb; 2():217-23. PubMed ID: 2860660
    [Abstract] [Full Text] [Related]

  • 8. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.
    Delfs JM, Ellison GD, Mercugliano M, Chesselet MF.
    Exp Neurol; 1995 Jun; 133(2):175-88. PubMed ID: 7544289
    [Abstract] [Full Text] [Related]

  • 9. Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias.
    Häggström JE, Gunne LM, Carlsson A, Wikström H.
    J Neural Transm; 1983 Jun; 58(3-4):135-42. PubMed ID: 6663299
    [Abstract] [Full Text] [Related]

  • 10. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1979 Jun 21; 63(3):195-8. PubMed ID: 39307
    [Abstract] [Full Text] [Related]

  • 11. Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.
    Häggström JE, Sjöquist B, Eckernäs SA, Ingvast A, Gunne LM.
    Acta Physiol Scand Suppl; 1984 Jun 21; 534():1-27. PubMed ID: 6150601
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluphenazine-induced acute and tardive dyskinesias in monkeys.
    Kovacic B, Domino EF.
    Psychopharmacology (Berl); 1984 Jun 21; 84(3):310-4. PubMed ID: 6440175
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
    Andersson U, Häggström JE.
    Psychopharmacology (Berl); 1988 Jun 21; 94(3):298-301. PubMed ID: 2895937
    [Abstract] [Full Text] [Related]

  • 16. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Kovacic B, Domino EF.
    J Clin Psychopharmacol; 1982 Oct 21; 2(5):305-7. PubMed ID: 6890075
    [Abstract] [Full Text] [Related]

  • 17. Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia.
    Ebadi M, Hama Y.
    Neurosci Biobehav Rev; 1988 Oct 21; 12(3-4):179-87. PubMed ID: 2906420
    [Abstract] [Full Text] [Related]

  • 18. Application of a primate model for tardive dyskinesia.
    Bárány S, Häggström JE, Gunne LM.
    Acta Pharmacol Toxicol (Copenh); 1983 Feb 21; 52(2):86-9. PubMed ID: 6846025
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.
    Mithani S, Atmadja S, Baimbridge KG, Fibiger HC.
    Psychopharmacology (Berl); 1987 Feb 21; 93(1):94-100. PubMed ID: 2888156
    [Abstract] [Full Text] [Related]

  • 20. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M, Chopra K, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1473-8. PubMed ID: 18554768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.